Nom |
6'-HYDROXYMÉTHYL SIMVASTATINE |
Synonymes |
[1S-[1a,3a,7a,8b(2S*,4S*),8ab]]-1,2,3,7,8,8a-hexahydro-3-(hydroxyméthyl)-7-méthyl-8-[2-(tétrahydro-4-hydroxy-6-oxo-2H-py ;[ Acide 1S-[1a,3a,7a,8b(2S*,4S*),8ab]]-1,2,3,7,8,8a-hexahydro-3-(hydroxyméthyl)-7-méthyl-8-[2-(tétrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)éthyl]-1-naphtalényle ester 2,2-diméthyl-butanoïque ; Acide 2,2-diméthylbutanoïque [1S-[1a,3a,7a,8(2S*,4S*),8a]]-1,2,3,7,8,8a-hexahydro-3-(hydroxyméthyl)-7-méthyl-8-[2-(tétrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)éthyl]-1-ester de naphtalényle ; (1S,3R,7S,8S,8aR)-3-(hydroxyméthyl)-8-{2-[(2R,4R)-4-hydroxy-6-oxotétrahydro-2H-pyran-2-yl]éthyl}-7-méthyl-1,2,3,7,8,8a-hexahydronaphtalène-1-yl 2,2-diméthylbutanoate |
Nom anglais |
6'-HYDROXYMETHYL SIMVASTATIN;[1S-[1a,3a,7a,8b(2S*,4S*),8ab]]-1,2,3,7,8,8a-hexahydro-3-(hydroxymethyl)-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-py; [1S-[1a,3a,7a,8b(2S*,4S*),8ab]]-1,2,3,7,8,8a-hexahydro-3-(hydroxymethyl)-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester 2,2-dimethyl-butanoic Acid; 2,2-Dimethylbutanoic Acid [1S-[1a,3a,7a,8(2S*,4S*),8a]]-1,2,3,7,8,8a-hexahydro-3-(hydroxymethyl)-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl Ester; (1S,3R,7S,8S,8aR)-3-(hydroxymethyl)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate |
Formule moléculaire |
C25H38O6 |
Poids Moléculaire |
434.5656 |
InChI |
InChI=1/C25H38O6/c1-5-25(3,4)24(29)31-21-11-16(14-26)10-17-7-6-15(2)20(23(17)21)9-8-19-12-18(27)13-22(28)30-19/h6-7,10,15-16,18-21,23,26-27H,5,8-9,11-14H2,1-4H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 |
Numéro de registre CAS |
128241-03-2 |
Structure moléculaire |
|
Densité |
1.16g/cm3 |
Point d'ébullition |
608.5°C at 760 mmHg |
Indice de réfraction |
1.543 |
Point d'éclair |
200.9°C |
Pression de vapeur |
2.4E-17mmHg at 25°C |
Les symboles de danger |
|
Codes des risques |
|
Description de sécurité |
|
|